chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12:00 a.m. Thursday  going into 5th day after vaccine, whole body very itchy - enough to wake up from sleep several times. Thursday and into Friday, on and off itchiness and raised bumps around elbows, behind knees, at wrists. Friday afternoon hives appeared (large welts pea sized/dime sized ) at bikini line, upper legs front/back, and sporadically on torso. No shortness of breath, no fever (remained 97.6) no racing heart rate. Benadryl tablet helped. On and off contunued reaction all weekend culminating in another outbreak on Sunday - Benadryl again helped- same symptoms. Called Urgent Care. No different food or drink consumed, using same detergents, not wearing any new, unwashed clothes, no new contact with animals. Only change in lifestyle was getting vaccine.
WAS IN GOOD HEALTH AT TIME OF INTRAMUSCULAR ADMINISTRATION OF INFLUENZA VACCINATION ON 10/13/08 AT RIGHT DELTOID. PAIN OVER RIGHT DELTOID ALMOST IMMEDIATELY AFTER ADMKNISTRATION.  PERSISTENT PAIN.  PAIN EXACERBATES WHEN ELEVATING RIGHT ARM > 90 DEGREES, LIFTING ANY OBJECT.  DIFFICULTY COMPLETING ADLS.  NO ERRYTHEMA, INDURATION.  NO RELIEF WITH NSAIDS, WARM MOIST HEAT, ICE.  WILL TREAT WITH FLEXERIL AND PHYSICAL THERAPY.
Cough, chills, fatigue, body ache, headache, runny nose, Tylenol.
extreme period cramps on 1st day; muscle pain on left arm; Tiredness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 18:30 (Lot number: EW0175) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Polycystic ovary syndrome" (unspecified if ongoing), notes: Polycystic ovary syndrome. There were no concomitant medications. The following information was reported: DYSMENORRHOEA (non-serious) with onset 2021, outcome "recovering", described as "extreme period cramps on 1st day"; MYALGIA (non-serious) with onset 2021, outcome "recovering", described as "muscle pain on left arm"; FATIGUE (non-serious) with onset 2021, outcome "recovering", described as "Tiredness". Therapeutic measures were not taken as a result of dysmenorrhoea, myalgia, fatigue.  Additional information: Patient had no know allergies. The patient didn't receive any other vaccines within 4 weeks of vaccination. No other medications the patient received within 2 weeks of vaccination. Side effect for 1st shot includes muscle pain on left arm, tiredness, extreme period cramps on 1st day  No follow-up attempts are possible. No further information is expected.
4-6-21 10:30 PM Chills, body aches, sore arm at sore of injection  4-7-21 12:00 AM High fever under 103, body aches, chills, migraine, sore arm at site of injection  4-7-21 12:30 PM High fever over 103.5, body aches, chills, loss of appetite, migraine, dizzy, sore swollen red arm at site of injection 4-8-21 12:00 AM Low fever under 101, body aches, chills, vomiting, migraine, dizzy, sore swollen red arm at site of injection  4-8-21 Remainder of the day no appetite, fever hovered around 100, migraine, sore swollen red arm at site of injection  4-9-21 Migraine, red sore swollen and itchy arm at site of injection
Extreme burning and redness of eyes, unable to tolerate contacts or bright light. Was unable to even use by eye wash as everything hurt my eyes, even to wear my glasses. Lasted for 2 days, some Benadryl eye drops brought a little relief on 2nd day, but still unable to tolerate contacts, which burned like fire when I would put them in, likewise with eyewash.
experiences a week long illness; Initial information received on 16-Dec-2019 regarding an unsolicited valid non-serious case received from a nurse.   This case is linked to case 2019SA354031 same reporter)  This case involves a 18 year old male patient who experienced a week long illness (ill-defined disorder), while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Past vaccination included INFLUENZA VACCINE (Flu Shot) with 2 years in a row. Medical history, medical treatment and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot number and other dosing details were not reported] via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious a week long illness (ill-defined disorder) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Details of laboratory data not reported.  Final diagnosis was ill-defined disorder.  It was not reported if the patient received any corrective treatment.  Event outcome is was Unknown for ill-defined disorder.  Information on the batch number was requested.
A report was received from a health care professional on 10/11/2002, concerning a female vaccinee in her 30's  who experienced a rash and an injection site reaction after receiving Fluvirin on 10/09/2002. On 10/09/2002, the vaccinee received a 0.5ml dose of Fluvirin. After an unknown period of time the vaccinee developed a rash, a soreness and a "knot" at the injection site. The vaccinee had not recovered at the time of the report. The reporter has assessed the relationship of the vaccine to the events as probable. Update1. 01/20/2003: A follow up report was received from a health care professioanl concerning a 31 year old female vaccinee who experienced hives after receiving Fluvirin intramuscularly in the left deltoid. The hives resolfved 1 day after vaccination on 10/10/2002/ The vaccinee had no previous exposure to Fluvirin,the vaccinee was treated with unspecified antihistamines. The reporter has assessed the relationship of the vaccine to the hives as probable.
Dad notice on 3/14/10, swollen on the elbow, redness. As per dad, given BENADRYL & MOTRIN. he apply ice to reduce swollen.
She felt lightheaded about 5 minutes after vaccination and fainted.  She says that she has had fainting incidents in the past.  She recovered quickly and remained in the pharmacy for a while after the incident.
Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 11:16 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 11:16 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the Reporter.   Its 30 days Expiry date vaccine went into 2 to 8 °C thaw state on or about to 24-Dec-2021, this vaccine administered until its Mfg date of 04-Apr-2022  No Treatment Medications were provided by the Reporter   This case was linked to MOD-2022-542869.
10 Minutes after administering vaccine patient c/o dizziness. H20 given and Pt jacket removed with recovery.
Patient received vaccine that was stored in the freezer for 19 days before moving to refrigerator.
head aches; double vision; This is a spontaneous report from a non-contactable consumer (patient). A 55-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown), via an unspecified route on 01Apr2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced head aches on 01Apr2021 and double vision on unspecified date in Apr2021. Patient stated that since he had the second shot Pfizer 01Apr2021, that same day he started having head aches and hasn't stopped since, last week Wednesday, he started having double vision that still exists, went to the eye doctor, bought new glasses. They want him to see a specialist next. Since he had the second shot this has been going on with him that is why he thought it was related to the vaccine. He asked is there anything else he should be doing. Response was a review of the prescribing information for Pfizer BIONTECH COVID 19 VACCINE did not find information regarding double vision. Pfizer cannot assess causality (i.e., cannot assess if what you described/are experiencing is associated with the Pfizer BIONTECH COVID 19 VACCINE). Beyond what is described in the <Pfizer BIONTECH COVID 19 VACCINE prescribing Information, Pfizer does not provide any recommendations regarding the management or treatment of potential adverse events/reactions/symptoms that a patient /consumer may experience. Your doctor/healthcare provider is in the best position to advise you about the appropriate action to take as your doctor/healthcare provider is most familiar with your medical condition, clinical history, how your treatment has been conducted and any relevant information to your specific case. There was no PQC present. The outcome of event was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
A physician reported that a 10 month old male received his first injection of Prevnar on 3/31/00. The next day, he developed a pinpoint rash. The reporter indicated that the infant had a viral upper respiratory tract infection at the time of vaccination. He recovered.
Fever; Chills; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided. The action taken for mRNA-1273 was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up information was received and had no new information.
This is a spontaneous report received from contactable reporter(s) (Other HCP). Other Case identifier(s): MOD-2022-571290. A male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Single, Manufacturer: Unknown, Verbatim: we were both vaccinated and boosted), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2, Single, Manufacturer: Unknown, Verbatim: we were both vaccinated and boosted), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), Single, Manufacturer: Unknown, Verbatim: we were both vaccinated and boosted), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "My husband received Pfizer, and had the same exact result of a re-infection". The reporter stated that her husband got Pfizer, she got Moderna, both were vaccinated and boosted. Our doctor prescribed Paxlovid and explained the benefit of eliminating the symptoms that go along with Covid-19. The fact that Pfizer just sent this over to Moderna is insulting. Her husband received Pfizer, and had the same exact result of a re-infection. So they were 100% in her household and that was with 2 different brands of vaccine. They both had the foul taste. Pfizer says that less than 5% of people are re-infected, and less than 2% have the foul taste, she questioned that after reading all the other accounts online of people who experienced the same exact effects they did, also they were 100% of the people who took Paxlovid experienced both of those things. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded.
Starting in February 2022 I started to have serious vertigo attacks.  3 in Feb. 2022, then one a month until June 2022.  In June I started have many each month: 7 in July and 5 in September.  They have been fewer and milder in 2023.
RUE firm edema & redness starting PM 10/18/11 with red line traveling near elbow to shoulder. Massive soft edema and redness (R) upper arm to elbow - especially back of arm.
Expired Kinrix adminsitered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number E2L53, expiry date 03-MAR-2023) for prophylaxis.   On 07-MAR-2023, the patient received Kinrix. On 07-MAR-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired Kinrix administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 7-Mar-2023 The reporter opted out of follow-up. The reporter did not consent to follow-up. The patient received an expired dose of Kinrix, which led to expired vaccine used.
No additional AEs or PQC reported; M-M-R II was administered to a 2 month old patient; This spontaneous report as received from a office manager  referring to a 2 month old patient, gender was not reported.The patient's medical history, concomitant medications, drug allergies, or reactions were not reported.     On 11-OCT-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) 0.5 milliliters, subcutaneously, lot # T001214, has been verified to be valid for measles, mumps, expiry date 12-JAN-2022 for prophylaxis (product administered to patient of inappropriate age).   No adverse event were reported.
Bexsero that expired 1/31/22 was administered; This case was reported by a other health professional via interactive digital media and described the occurrence of expired vaccine used in a patient who received Men B NVS (Bexsero) (batch number unknown, expiry date 31st January 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 6-APR-2022 Reporter's Comment: The reporter reported this case via interactive digital media. The reporter stated that the expired Bexsero vaccine was accidentally administered to a patient. Additional supportive information:  The patient received a dose of Bexsero which was already expired, which led to expired vaccine used. The follow-up would not possible, as no contact details were available. The case had been linked to US2022061072, reported for the possibly same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022061072:Possibly same patient
After administration of vaccine, we were notified by Agency that the vaccine had experienced a temperature monitoring event outside of our facility.  Patient was notified of CDC guidelines that recommend revaccination.  Patient came in 10/20/2022 for revaccination.
lymphadenopathy under the arm of the vaccine (left) and to the right of the sternum.  chills for 7 days.  Fatigue for 7 days
ringing in the ears following a Moderna COVID-19 vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in the ears following a Moderna COVID-19 vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced TINNITUS (ringing in the ears following a Moderna COVID-19 vaccine.). At the time of the report, TINNITUS (ringing in the ears following a Moderna COVID-19 vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. No Treatment information was reported.
Child received 4 year old vaccinations on 12/6/2007.  That evening her left arm became swollen, hard, red, and hot. No fever.  Her mother called family MD, who told her to put warm compress on area.  On 12/7/07 her arm did not improve.  No further symptoms.  Mom took her to local hospital ER.  MD evaluated child, stated she had a local allergic reaction.  Benadryl was given.  Mom told that child should not receive vaccines again.
Fever- Started in the middle of the night around 1:00 am and dizziness felt like I was going to pass out.  Woke up at 8 with a slight cough, dizziness and faint feeling.
Developed a diffuse itchy rash, swelling around eyes and lips. Took antihistamines which helped.  Woke up around 2 am with itch, took some more antihistamines.  Woke up at 6 am with puffy eyes and lips.  Took more antihistamines.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 16-SEP-2016, the patient received an improperly stored dose of ZOSTAVAX (lot # M009773, expiration date 17-MAY-2017; dose and route were unknown). No adverse effects were reported. Additional information has been requested.
pt recv vax 22FEB96 & 22MAR96 exp erythema multiforme;hands, feet & tongue was involved suggesting possible stevens-johnson synd;MD visit was required;sx lasted 5-7 days;MD is also considering that the rxn may be d/t Zantac;
Mild fever (101); Chills; This is a spontaneous report from a contactable consumer. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration on 01May2021 at 13:30 hours (at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL) and dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL): both from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 02:00 hours, the patient experienced mild fever (101) and chills. The patient underwent lab test and procedures, which included Body temperature and the result was 101 unit unspecified. Therapeutic measures were taken as a result of mild fever (101) and chills and included treatment with Tylenol. The clinical outcomes of the mild fever (101) and chills was recovering.  No follow-up attempts are needed. No further information is expected.
severe pain in left elbow and muscles in upper left back. pain seems to radiate from the point of vaccination.
SEVERE head ache and SEVERE body aches, with chills and low grade fever. I was also tired, nauseous, and felt  malaise. My injection arm hurt from my fingers to my shoulder.  I could not lift or even use that arm at all. The pain from the vaccine was equal if not worse than  actually having Covid. I got side effects  right away. I came home from the vaccine on Thursday and took a nap, I wasnt able to function again until today, Sunday. I?m still getting sharp stabbing pain in my back, have a mild head ache and am still fatigued; but am far better than I was yesterday.   I did call a telehealth doctor on Friday to see what I could take to help with the pain, and the doctor recommended  Tylenol and Ibuprofen. I did take Tylenol but after reading what I could online I decided against the Ibuprofen.
Pt had 2 vaccines 8/30/06 on left deltoid. 3 days after noticed increasing redness, soreness and area of shot warm to touch. Saw 2 different Drs on separate occasion and was started on antibiotics. Pt diagnosed with cellulitis.
Patient had minor pain and swelling and then in about 3 days a rash started that developed into small blisters and is improving but has been present for over 2 weeks. The rash is also itching her. The symptoms are improving but not gone after two weeks
Blood sugar reading abnormally high (218) then about 45 minutes later it hand went down to the 170's.
Suffered Heart Attack on Thursday, November 17 at approximately 1:00pm.  Upon diagnosis at local emergency clinic was taken by Ambulance to the local Hospital for Heart Cath procedure.   Heart Cath was performed and resulted in no blockages and no stents and places of one balloon.   Blood clot had broken away and blocked smaller artery supporting bottom right quadrant of heart.
Nausea/vomiting, fever at highest was 102.5 degrees F.
Around 4 hours after vaccination on 9/23/23,  the patient began experiencing extreme fatigue and aching in all joints and developed a severe headache.  She went to bed early but was unable to sleep that night.  The next morning, she felt dizzy and nauseous.  She felt an urgency to go to the bathroom but no diarrhea.  She also had chills and fever Saturday night 9/23/23 through Sunday and Monday.  The chills were not as severe on Monday.  She experienced vomiting periodically Sunday 9/24/23 , beginning  late morning  and continuing through Sunday evening.  She feels like her voice is altered currently but does not have a sore throat.
Developed anisometropia and esotropia within 2 days of getting the vaccines.  Within a week, foound to have pappilledema and Idiopathic Intracranial hypertension.